Editorial
doi: 10.1200/JCO.2003.02.044.
Combining cytotoxic chemotherapy with cyclooxygenase-2 inhibition
- PMID: 12860936
- DOI: 10.1200/JCO.2003.02.044
Item in Clipboard
Editorial
Combining cytotoxic chemotherapy with cyclooxygenase-2 inhibition
J Clin Oncol.
.
No abstract available
Comment on
-
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer.J Clin Oncol. 2003 Jul 15;21(14):2645-50. doi: 10.1200/JCO.2003.07.127. J Clin Oncol. 2003. PMID: 12860939 Clinical Trial.
Similar articles
-
[Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].Aktuelle Urol. 2004 Aug;35(4):331-8. doi: 10.1055/s-2004-818537. Aktuelle Urol. 2004. PMID: 15459875 German.
-
Why cyclooxygenase-2 inhibition plus chemotherapy?Am J Clin Oncol. 2003 Aug;26(4):S122-5. doi: 10.1097/01.COC.0000074150.99253.26. Am J Clin Oncol. 2003. PMID: 12902869 Review.
-
Inhaled indomethacin in bronchorrhea in bronchioloalveolar carcinoma: role of cyclooxygenase.Chest. 2000 Apr;117(4):1213-4. doi: 10.1378/chest.117.4.1213. Chest. 2000. PMID: 10767270 No abstract available.
-
Thalidomide, cyclooxygenase-2, and angiogenesis: potential for therapy.Clin Cancer Res. 2001 Nov;7(11):3311-3. Clin Cancer Res. 2001. PMID: 11705841 No abstract available.
-
Cyclooxygenase (COX) inhibitors: a comparative QSAR study.Chem Rev. 2003 Mar;103(3):703-32. doi: 10.1021/cr020464a. Chem Rev. 2003. PMID: 12630850 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
